Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LIPO - LIPELLA PHARMACEUTICALS INC.

IEX Last Trade
3.23
0   0%

Share volume: 352
Last Updated: Thu 26 Dec 2024 08:20:38 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): -0.11%

PREVIOUS CLOSE
CHG
CHG%
$3.23
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
2.00%
1 Month
12.93%
3 Months
522.69%
6 Months
572.77%
1 Year
225.98%
2 Year
-21.15%
Key data
Stock price
$3.23
P/E Ratio 
0.00
DAY RANGE
$3.13 - $3.24
EPS 
$0.00
52 WEEK RANGE
$0.32 - $3.56
52 WEEK CHANGE
$213.07
MARKET CAP 
3.362 M
YIELD 
N/A
SHARES OUTSTANDING 
8.005 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$82,286
AVERAGE 30 VOLUME 
$173,087
Company detail
CEO: Jon Kaufman
Region: US
Website: lipella.com
Employees: 4
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

We are a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Our principal executive offices are located at 7800 Susquehanna Street, Suite 505, Pittsburgh, PA.

Recent news